Effects of IL-6 and AG490 on regulation of Stat3 signaling pathway and invasion of human pancreatic cancer cells in vitro

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Huang, Chen ^a   Yang, Guang ^b   Jiang, Tao ^a   Huang, Kejian ^a   Cao, Jun ^a   Qiu, Zhengjun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Taian Central Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; INTERLEUKIN 6; MESSENGER RNA; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; STAT3 PROTEIN; VASCULOTROPIN RECEPTOR; ALPHA CYANO (3,4 DIHYDROXY) N BENZYLCINNAMIDE; ALPHA-CYANO-(3,4-DIHYDROXY)-N-BENZYLCINNAMIDE; ANTINEOPLASTIC AGENT; TYRPHOSTIN; VASCULOTROPIN A;

ARTICLE; CAPAN-2 CELL LINE; CELL GROWTH; CELL INVASION ASSAY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MTT ASSAY; PANCREAS CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SW1990 CELL LINE; TUMOR INVASION; WESTERN BLOTTING; CELL MOTION; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; PANCREAS TUMOR; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; INTERLEUKIN-6; MATRIX METALLOPROTEINASE 2; PANCREATIC NEOPLASMS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TYRPHOSTINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77952315859     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-51     Document Type: Article

References (34)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 2007, 57: 43-66.
2. Postier RG: The challenge of pancreatic cancer. Am J Surg 2003, 186:579-582.
3. Neoptolemos JP, Cunningham D, Friess H, Bassi C, Stocken DD, Tait DM, et al.: Adjuvant therapy in pancreatic cancer: historical and current perspectives. Ann Oncol 2003, 14:675-692.
4. Bromberg J, Darnell JE Jr: The role of STATs in transcriptional control and their impact on cellular function. Oncogene 2000, 19:2468-2473.
5. Huang S: Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Clin Cancer Res 2007, 13:1362-1366.
6. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, et al.: Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 2002, 21:2000-2008.
7. Xie TX, Wei D, Liu M, Gao AC, Ali-Osman F, Sawaya R, et al.: Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 2004, 23: 3550-3560.
8. Scholz A, Heinze S, Detjen KM, Peters M, Welzel M, Hauff P, et al.: Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer. Gastroenterology 2003, 125:891-905.
9. Yu LF, Cheng Y, Qiao MM, Zhang YP, Wu YL: Activation of STAT3 signaling in human stomach adenocarcinoma drug-resistant cell line and its relationship with expression of vascular endothelial growth factor. World J Gastroenterol 2005, 11:875-879.
10. Lee SO, Lou W, Qureshi KM, Mehraein-Ghomi F, Trump DL, Gao AC: RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells. Prostate 2004, 60:303-309.
11. Zhang F, Li C, Halfter H, Liu J: Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells. Oncogene 2003, 22:894-905.
12. Alvarez JV, Greulich H, Sellers WR, Meyerson M, Frank DA: Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor. Cancer Res 2006, 66:3162-3168.
13. Shen Y, Devgan G, Darnell JE Jr, Bromberg JF: Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc Natl Acad Sci USA 2001, 98:1543-1548.
14. Zamo A, Chiarle R, Piva R, Howes J, Fan Y, Chilosi M, et al.: Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. Oncogene 2002, 21:1038-1047.
15. Blaskovich MA, Sun J, Cantor A, Turkson J, Jove R, Sebti SM: Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res 2003, 63: 1270-1279.
16. Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, et al.: Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Cancer Res 2002, 62:6659-6666.
17. Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, et al.: Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 1996, 379:645-648.
18. Xiong H, Zhang ZG, Tian XQ, Sun DF, Liang QC, Zhang YJ, et al.: Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. Neoplasia 2008, 10:287-297.
19. Yang J, Liao X, Agarwal MK, Barnes L, Auron PE, Stark GR: Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev 2007, 21:1396-1408.
20. Sekikawa A, Fukui H, Fujii S, Ichikawa K, Tomita S, Imura J, et al.: REG Ialpha protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells. Carcinogenesis 2008, 29:76-83.
21. Hodge DR, Hurt EM, Farrar WL: The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 2005, 41:2502-2512.
22. Bowman T, Garcia R, Turkson J, Jove R: STATs in oncogenesis. Oncogene 2000, 19:2474-2488.
23. Qiu Z, Huang C, Sun J, Qiu W, Zhang J, Li H, et al.: RNA interferencemediated signal transducers and activators of transcription 3 gene silencing inhibits invasion and metastasis of human pancreatic cancer cells. Cancer Sci 2007, 98:1099-1106.
24. Huang C, Cao J, Huang KJ, Zhang F, Jiang T, Zhu L, et al.: Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in vitro. Cancer Sci 2006, 97:1417-1423.
25. Haura EB, Turkson J, Jove R: Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer. Nat Clin Pract Oncol 2005, 2: 315-324.
26. Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, et al.: Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer. Cancer Lett 2003, 201:107-116.
27. Chang KC, Wu MH, Jones D, Chen FF, Tseng YL: Activation of STAT3 in thymic epithelial tumours correlates with tumour type and clinical behaviour. J Pathol 2006, 210:224-233.
28. Kusaba T, Nakayama T, Yamazumi K, Yakata Y, Yoshizaki A, Nagayasu T, et al.: Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors. J Clin Pathol 2005, 58: 833-838.
29. Suiqing C, Min Z, Lirong C: Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma. J Dermatol 2005, 32:354-360.
30. Grunstein J, Roberts WG, Mathieu-Costello O, Hanahan D, Johnson RS: Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function. Cancer Res 1999, 59:1592-1598.
31. Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, et al.: Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 2003, 22:319-329.
32. Matsuyama Y, Takao S, Aikou T: Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas. J Surg Oncol 2002, 80:105-110.
33. Tan X, Egami H, Ishikawa S, Sugita H, Kamohara H, Nakagawa M, et al.: Involvement of matrix metalloproteinase-7 in invasion-metastasis through induction of cell dissociation in pancreatic cancer. Int J Oncol 2005, 26:1283-1289.
34. Xie TX, Huang FJ, Aldape KD, Kang SH, Liu M, Gershenwald JE, et al.: Activation of stat3 in human melanoma promotes brain metastasis. Cancer Res 2006, 66:3188-3196.